Most conventional antidepressants reduce cortisol levels over time, so there is no single “best” choice dedicated to that purpose. That said, mirtazapine has the most direct head-to-head evidence for reliably lowering cortisol compared with other commonly prescribed antidepressants, and it does so within the first week of treatment. The fuller picture is more interesting than a simple drug ranking, though, because the relationship between cortisol, depression, and medication is shaped by factors like depression subtype, age, sex, and whether you are also doing therapy.
How Antidepressants Influence Cortisol in General
Depression frequently involves an overactive stress-hormone system. People with current or even past major depression tend to have a higher cortisol awakening response compared with people who have never been depressed.1JAMA Psychiatry. Major Depressive Disorder and Hypothalamic-Pituitary-Adrenal Axis Activity: Results From a Large Cohort Study The stress system gets stuck in a loop: the brain sends too many alarm signals, the adrenal glands keep pumping out cortisol, and the receptors that should tell the brain to dial things down stop working properly.
Antidepressants appear to interrupt this loop. Research across drug classes shows that they boost the expression and function of glucocorticoid receptors in the brain, which helps restore the feedback mechanism that tells the body to stop producing cortisol.2PubMed Central. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? In practical terms, most studies of antidepressants find they are linked to lower basal cortisol and improved cortisol suppression on standard tests, though some individual studies report no change.3Schizophrenia Research. Psychotropic medication effects on cortisol: Implications for research and mechanisms of drug action The key nuance is timing: a single dose of an antidepressant often temporarily raises cortisol, while chronic treatment over weeks tends to bring it down.4PubMed Central. A placebo-controlled study of sertraline’s effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adults
SSRIs and the Cortisol Timeline
Selective serotonin reuptake inhibitors are the most commonly prescribed antidepressants, and they have been the most studied for cortisol effects. The picture they paint is a bit more layered than “SSRIs lower cortisol.” In healthy women given escitalopram for six days, the drug steepened the cortisol slope across the day by raising waking cortisol levels, without reducing overall daily cortisol output.5PubMed Central. The effects of six-day SSRI administration on diurnal cortisol secretion in healthy volunteers In other words, short-term SSRI use can actually nudge certain cortisol measures upward before any long-term dampening kicks in.
Longer treatment tells a different story. In depressed patients taking paroxetine over twelve weeks, basal cortisol levels and total daily cortisol output dropped significantly. Patients who eventually achieved remission also showed a healthy increase in their cortisol awakening response, a sign that the stress system was regaining its normal rhythm rather than simply being blunted across the board.6PubMed. Longitudinal effects of the SSRI paroxetine on salivary cortisol in Major Depressive Disorder Fluoxetine also reduced cortisol after eight weeks in depressed patients, performing comparably to the omega-3 fatty acid EPA on that measure.7Psychiatry Research. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder
So SSRIs do lower cortisol, but the effect is gradual and tracks with clinical improvement. If you are two weeks into an SSRI and your cortisol has not budged, that is entirely expected.
Mirtazapine in Head-to-Head Comparisons
Mirtazapine is where the cortisol-lowering story gets most interesting. In a randomized trial that directly compared mirtazapine with venlafaxine (an SNRI) in depressed patients, mirtazapine lowered afternoon salivary cortisol starting in the first week and maintained that effect over four weeks. Venlafaxine, by contrast, did not lower cortisol at all during the same treatment period.8PubMed. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial That is a clean, direct comparison showing mirtazapine outperforming a commonly used alternative on this specific outcome.
The mechanism behind mirtazapine’s cortisol-lowering effect has been studied in healthy volunteers as well. A single 15-milligram dose significantly reduced cortisol output, ACTH output, and urinary free cortisol compared with placebo.9PubMed. Endocrinological effects of mirtazapine in healthy volunteers Mirtazapine blocks certain serotonin and histamine receptors that stimulate the stress-hormone cascade, which likely explains why its cortisol-lowering action appears so quickly rather than taking weeks like SSRIs.
If lowering cortisol were the sole objective, mirtazapine has the strongest standalone evidence among standard antidepressants. The tradeoff is that mirtazapine carries its own side-effect profile, including weight gain and sedation, which may make it a poor fit for some people regardless of its cortisol effects.
SNRIs and Bupropion
Venlafaxine’s lack of cortisol-lowering effect in the mirtazapine comparison study does not necessarily condemn all SNRIs, but it does mean the class has weaker evidence on this specific endpoint. The dual serotonin-norepinephrine mechanism of SNRIs might stimulate the stress axis through norepinephrine pathways at the same time it dampens it through serotonin pathways, leading to a wash.
Bupropion, which works primarily on dopamine and norepinephrine, has been studied in depressed patients alongside paroxetine. Both treatment groups showed blunted cortisol responses to mental stressors compared with untreated controls, suggesting that bupropion does reduce stress-related cortisol output.10Journal of Affective Disorders. Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients The reduction was comparable between the two drugs. Bupropion’s cortisol-lowering effect appeared to operate specifically during stress rather than by lowering baseline levels, which makes it a useful option for people whose cortisol spikes are mainly triggered by stressful situations.
Tianeptine and Stress-Evoked Cortisol
Tianeptine is an atypical antidepressant used in several European and Latin American countries but not approved in the United States. It works through a different mechanism than most antidepressants, acting on opioid receptors and glutamate signaling rather than serotonin reuptake. Animal research shows it has unusually potent effects on stress-evoked cortisol. A single dose significantly reduced both ACTH and corticosterone levels triggered by stress.11PubMed. The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis Chronic treatment went further, abolishing the depletion of the brain’s corticotropin-releasing factor stores that normally occurs with repeated stress.12European Journal of Pharmacology. Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis
The limitation is that tianeptine’s cortisol data come primarily from animal studies, so direct translation to human cortisol management remains uncertain. For people with access to tianeptine who are specifically seeking stress-axis stabilization, these findings are encouraging, but they are not in the same evidence tier as the human trial data behind SSRIs or mirtazapine.
Why Ketamine Is Not a Cortisol-Lowering Option
Ketamine and its derivative esketamine have gained attention as rapid-acting treatments for severe depression. On the cortisol front, though, they do the opposite of what you might hope. In healthy subjects, a subanesthetic ketamine infusion roughly doubled plasma cortisol levels by the end of the infusion, and saliva cortisol peaked at about five times the placebo level shortly afterward.13British Journal of Anaesthesia. Effect of subanaesthetic ketamine on plasma and saliva cortisol secretion Other studies in both humans and animals confirm a rapid, dose-dependent spike in cortisol following ketamine administration.14PubMed. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects15PubMed Central. Time of day influences stress hormone response to ketamine
This cortisol surge is transient and probably part of how ketamine exerts its rapid antidepressant effect, but it means ketamine is not a tool for cortisol reduction. Anyone specifically trying to lower chronically elevated cortisol should not expect ketamine to help with that goal, even if it helps their depression through other mechanisms.
Atypical Antipsychotics as Add-Ons
When depression does not respond fully to a standard antidepressant, clinicians sometimes add a low-dose atypical antipsychotic. These drugs happen to have notable cortisol-lowering effects in their own right. Quetiapine and olanzapine both significantly reduced ACTH and cortisol secretion compared with placebo in healthy subjects.16PubMed. The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects Ziprasidone also reduced total cortisol output and blocked the cortisol spike normally caused by acoustic stress.17PubMed Central. Ziprasidone decreases cortisol excretion in healthy subjects A broader review of clinical studies concluded that antipsychotic treatment either reduces cortisol or has no effect, with no evidence that it raises cortisol.18PubMed Central. Psychotropic Drug Effects on Steroid Stress Hormone Release and Possible Mechanisms Involved
This is relevant for treatment-resistant depression where an antidepressant alone has not normalized cortisol. Augmenting with quetiapine or olanzapine could provide additional cortisol reduction on top of the antidepressant’s own effects. The tradeoff, again, is the side-effect burden: metabolic changes, sedation, and weight gain are common concerns with these drugs.
Cortisol Changes Early in Treatment Can Predict Outcomes
One of the more practical findings in this area is that early cortisol changes may signal whether a given antidepressant is going to work for you. In a study of hospitalized depressed patients, those whose cortisol response on a standard suppression test improved within the first two to three weeks of treatment were significantly more likely to respond to treatment and achieve remission by the end of hospitalization.19Biological Psychiatry. Combined Dexamethasone/Corticotropin Releasing Hormone Test Predicts Treatment Response in Major Depression–A Potential Biomarker? Another study found that patients whose cortisol peaked lower on the same test after just one week of treatment showed a greater reduction in depression scores over the following weeks.20PLOS ONE. The Combined Dexamethasone/CRH Test (DEX/CRH Test) and Prediction of Acute Treatment Response in Major Depression
These findings suggest that cortisol testing could eventually become a practical tool for deciding whether to stick with a medication or switch early. That is not routine clinical practice yet, but researchers have been working toward it for years.
When High Cortisol Is Not Actually the Problem
Here is where the “best antidepressant to lower cortisol” question gets complicated. Not all depression involves elevated cortisol. A review of the translational evidence found that a high cortisol response to stress is associated with acute and severe forms of depression, but not with mild or atypical depression.21PubMed Central. Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back Atypical depression, characterized by oversleeping, heaviness in the limbs, and increased appetite, tends to involve normal or even lower-than-normal cortisol levels. Trying to lower cortisol further in someone whose cortisol is already low would be counterproductive.
The same review came to a sobering conclusion: despite the fact that almost all current antidepressants influence cortisol levels, there is no convincing evidence that the degree of cortisol reduction predicts whether the treatment will work.21PubMed Central. Cortisol and Major Depressive Disorder-Translating Findings From Humans to Animal Models and Back Cortisol lowering appears to be something antidepressants do, rather than the reason they relieve depression. Choosing a drug purely for its cortisol-lowering ability misses this distinction.
For people with treatment-resistant psychotic depression and measurably high cortisol, there is a different approach: antiglucocorticoid drugs. Mifepristone, a glucocorticoid receptor blocker, showed meaningful reduction in psychotic symptoms in combined analyses, with patients who achieved high blood levels of the drug having particularly strong responses over placebo.22PubMed. Combined Analysis of Mifepristone for Psychotic Depression: Plasma Levels Associated With Clinical Response Cortisol synthesis inhibitors also appear to work better in patients with higher baseline cortisol.23Psychoneuroendocrinology. Baseline cortisol and the efficacy of antiglucocorticoid treatment in mood disorders: A meta-analysis These drugs are not standard antidepressants, but they represent a more targeted approach for the subset of patients whose depression is genuinely cortisol-driven.
Age Changes the Cortisol-Treatment Relationship
If you are older, the entire cortisol-depression relationship may be flipped from what you would expect. In a retrospective analysis of depressed patients, age significantly moderated how cortisol related to treatment outcomes. For younger adults below the sample’s median age, lower cortisol was associated with lower rates of depression and better antidepressant response. For older adults above the median age, the opposite held: lower cortisol was associated with higher rates of depression and less improvement with antidepressant treatment.24PubMed Central. Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis
This finding makes intuitive sense when you consider that cortisol levels naturally rise with age, and the brain’s sensitivity to cortisol shifts over time. An older adult with depression and unusually low cortisol may have a very different biological underpinning than a younger adult with depression and high cortisol. Picking an antidepressant specifically for cortisol lowering could be the wrong move for an older person whose cortisol is already on the low side.
Sex Differences in Stress-Hormone Response
Women and men respond differently to the same antidepressant when it comes to cortisol. In mice, the SSRI citalopram produced a larger cortisol response in females than in males, independent of any stressor, and testosterone treatment in females “masculinized” the response back down.25Endocrinology. Sex Differences in the Serotonergic Influence on the Hypothalamic-Pituitary-Adrenal Stress Axis The study found sex differences at multiple points in the stress circuit, including more serotonin receptors in the pituitary and larger adrenal glands in females, as well as stronger inhibitory feedback mechanisms in males.
A broader review of how sex differences affect antidepressant development raised an uncomfortable point: many of the novel drugs designed to target the stress-hormone system were studied preclinically in male animals but then tested in clinical trials that enrolled mostly or exclusively women. The mismatch between preclinical and clinical populations may have contributed to the failure of several promising drug candidates.26PubMed Central. Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development? For individual patients, the takeaway is that a drug’s cortisol-lowering effect documented in a mixed or male-dominated study may not translate directly to a woman’s experience, and vice versa. The evidence here specifically from the escitalopram study in healthy volunteers also found that the short-term cortisol changes occurred in women but would need separate confirmation in men.5PubMed Central. The effects of six-day SSRI administration on diurnal cortisol secretion in healthy volunteers
Adding Therapy to Medication
If you are already on an antidepressant and still concerned about cortisol, adding cognitive-behavioral therapy may provide additional benefit. In a randomized trial of older adults with generalized anxiety disorder who were already taking escitalopram, those who also received CBT showed a significant reduction in peak cortisol levels at the end of treatment. The group taking escitalopram alone actually had a slight increase in peak cortisol over the same period.27PubMed Central. Cognitive-Behavioral Therapy Augmentation of SSRI Reduces Cortisol Levels in Older Adults with Generalized Anxiety Disorder: A Randomized Clinical Trial
This result is striking because it suggests that medication and therapy are not redundant when it comes to cortisol. The SSRI stabilizes neurotransmitter signaling while CBT teaches the brain new ways to interpret and respond to stressors, and together they may address cortisol dysregulation from both sides. For someone whose cortisol has not normalized on medication alone, therapy is probably a more evidence-based next step than switching to another antidepressant purely for its cortisol profile.
The Neurogenesis Connection
Chronically elevated cortisol is not just a marker of depression; it does its own damage. High cortisol exposure slows the birth of new neurons in the hippocampus and can lead to measurable shrinkage of that brain region over time.28PubMed. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment Chronic antidepressant treatment pushes back in the opposite direction, upregulating the production of new neurons and potentially reversing some of the structural damage caused by prolonged stress.29PubMed. Is neurogenesis relevant in depression and in the mechanism of antidepressant drug action? A critical review This dual action, lowering the cortisol that suppresses new cell growth while independently promoting neurogenesis, is part of why antidepressant treatment takes weeks to produce its full effect. The cortisol reduction matters not because it is the antidepressant mechanism itself, but because it creates a less hostile environment for the brain’s own repair processes.
For people weighing whether cortisol reduction should influence their medication choice, this context helps frame the decision. Cortisol lowering is one piece of a larger recovery process. The antidepressant that produces the best overall clinical response for your specific depression is almost certainly doing useful things to cortisol along the way, whether or not you are measuring it.